Insulin resistance (IR), defined as a reduced physiological response to insulin in target tissues, is recognized as a pathogenic induction factor for various metabolic syndromes, including nonalcoholic fatty liver disease (NAFLD), atherosclerosis, and type 2 diabetes mellitus (T2DM) [1,2]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.